Organovo (ONVO) says preclinical development will be extended into calendar 2020

May 22, 2019 4:10 PM

Organovo Holdings, Inc. (NASDAQ: ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found